Skip Navigation
Find a Doctor


Photo of Dr. Karen Smith

Karen Lisa Smith, M.D., M.P.H.

Clinical Associate, Breast Cancer Program, Johns Hopkins Kimmel Cancer Center


Main Location

Sibley Memorial Hospital


  • Clinical Associate, Breast Cancer Program, Johns Hopkins Kimmel Cancer Center

Centers & Institutes


  • Oncology
  • Medicine at Sibley Memorial Hospital


Sibley Memorial Hospital

5255 Loughboro Road NW
Washington, DC 20016 map
Phone: 202-537-4787


Breast Cancer, Cancer Genetics, Cancer Survivorship, Medical Oncology

Research Interests

Breast Cancer, Cancer Survivorship, breast cancer clinical trials, toxicities of cancer therapies, hereditary breast cancer, triple negative breast ancer, physician-patient communications and racial disparities


Dr. Smith is a medical oncologist with expertise in
caring for breast cancer patients. She also has interests
in cancer genetics, cancer survivorship, minimizing
toxicity of cancer treatments, physician-patient
communication and clinical trials. She is a member of the Johns Hopkins Breast Cancer Program. more

    Additional Information

  • Education +


    • Rush Medical College / MD (1998)


    • American Board of Internal Medicine / Internal Medicine (2002, 2012)
    • American Board of Internal Medicine / Medical Oncology (2006, 2016)
  • Research & Publications +

    Clinical Trial Keywords: Breast cancer clinical trials

    Selected Publications

    Peer-Reviewed Papers:

    Smith K, Wray L, Klein-Carbal M, Schuchter L, Fox K, Glick J, Demichele A. Racial Disparities in Adjuvant Chemotherapy for Breast Cancer are not due to Excess Toxicity in African Americans. Clinical Breast Cancer. Vol 6, 2005:260-6.

    Smith, KL, Adank M, Kauff N, Lafaro K, Boyd J, Lee J, Hudis C, Offit K, Robson M. BRCA Mutations in Women with Ductal Carcinoma in Situ: Prevalence and Risk Factors. Clinical Cancer Research. Vol 13, 2007:4306-10.

    Dang C, DAndrea G, Lake D, Sugarman S, Fornier M, Moynahan ME, Gilewski T, Hurria A, Mills N, Troso-Sandoval T, George R, Robson M, Dickler M, Smith K, Panageas KS, Norton L, Hudis CA. Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible. Clinical Breast Cancer 2008 Oct;8(5):418-24.

    Isaacs C, Herbolsheimer P, Liu M, Wilkinson M, Ottaviano Y, Chung G, Warren R, Eng-Wong J, Cohen P, Smith KL, Creswell K, Novielli A, Slack R. Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer. Breast Cancer Research and Treatment. Vol 125, 2011:137-143.

    Herbolsheimer P, Kapoor R, Smith KL, Perry D, Verma N, Veytsman I, Jelinek J, Swain SM. Phase I trial of dasatinib and ixabepilone in patients with solid tumors. Investigational New Drugs. 2012 Mar 6, epub ahead of print.

    Khozin S, Roth MJ, Rajan A, Smith K, Thomas A, Berman A, Giaccone G. Hepatoid carcinoma of the lung with anaplastic lymphoma kinase gene rearrangement. Journal of Thoracic COncology. 2012 Nov;7(11):e29-31.

    Reviews and Chapters:

    Smith K. Patient 48: A 58-year old woman with ductal carcinoma in situ. In: Danso MA, Basch EM, eds. Hematology and Oncology Pearls. Philadelphia: Elsevier Mosby, 2005.

    Smith K. Patient 51: A 48-year old woman with stage II breast cancer. In: Danso MA, Basch EM, eds. Hematology and Oncology Pearls. Philadelphia: Elsevier Mosby, 2005.

    Smith K. Patient 69: A 56-year old woman with hormone-receptor-positive early-stage breast cancer. In: Danso MA, Basch EM, eds. Hematology and Oncology Pearls. Philadelphia: Elsevier Mosby, 2005.

    Smith KL, Robson M. Update on Hereditary Breast Cancer. Current Oncology Reports. Vol 8, 2006:14-21.

    Smith KL, Dang C, Seidman A. Cardiac Dysfunction Associated with Trastuzumab. Expert Opinion on Drug Safety. Vol 5, 2006: 619-29.

    Demarco TA, Smith KL, Nusbaum RH, Peshkin BN, Schwartz MD, Isaacs C. Practical Aspects of Delivering Hereditary Cancer Risk Counseling. Seminars in Oncology. Vol 34, 2007: 369-378.

    Smith KL, Isaacs C. Management of Women at Increased Risk for Hereditary Breast Cancer. Breast Disease: An International Journal. Vol 27, 2006-2007: 51-67.

    Smith KL, Isaacs C. Chapter 15: Breast Cancer Screening and Prevention Options in BRCA1 and BRCA2 Mutation Carriers. In: Hereditary Breast Cancer. Editors: Isaacs C, Rebbeck TA. Informa Healthcare. New York, 2008.

    Smith KL, Isaacs C. Poly(ADP-Ribose) Inhibition: Exploring a New Approach to Breast Cancer Prevention in BRCA1/2 Mutation Carriers. Current Breast Cancer Reports. Epub July 1, 2011.

    Smith KL, Isaacs C. BRCA Mutation Testing in Determining Breast Cancer Treatment. The Cancer Journal. Volume 17, 2011:492-499.

  • Academic Affiliations & Courses +
  • Activities & Honors +


    • Merit-Based Scholarship, Johns Hopkins Bloomberg School of Public Health, 2002 - 2003
    • Master of Public Health Capstone Award, Johns Hopkins Bloomberg School of Public Health , 2003
    • Merit Award, ASCO Foundation, 2005
    • Young Investigator Award, ASCO Foundation, 2005
    • Merit Award, ASCO Foundation, 2006


    • American Society of Clinical Oncology, 2003
    • Housestaff Hematology/Oncology Rotation, 2007 - 2011
    • Cancer Committee, 2008 - 2013
    • Breast Cancer Survivorship Committee, 2011 - 2013
    • Clinical Review Committee Medstar South, 2011 - 2013

    Professional Activities

    • Director, Medstar Washington Hospital Center, 2007 - 2011
      Housestaff Hematology/Oncology Rotation
    • Chair, MedStar Washington Hospital Center, 2008 - 2013
      Cancer Committee
    • Chair, Medstar Washington Hospital Center, 2011 - 2013
      Breast Cancer Survivorship Committee
  • Videos & Media +
Is This You? Edit Profile

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.